Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pain 7 Neoplasms 3 Pain, Postoperative 2 Malignant Female Reproductive System Neoplasm 2 Hematologic Neoplasms 2 Emergencies 2 Agnosia 2 Uterine Cervical Neoplasms 1 Tumor Surgery 1 Sarcoma 1 Rectal Neoplasms 1 Pulmonary Nodule 1 Prostatic Neoplasms 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Ovarian Neoplasms 1 Neuralgia 1 Neoplasm Metastasis 1 Mucositis 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Leukemia 1 Kidney Neoplasms 1 Intraoperative Complications 1 Ileus 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Duodenal Neoplasms 1 Diverticulosis, Colonic 1

Interventions

Sunitinib 26 Everolimus 20 Bevacizumab 19 aldesleukin 18 Sorafenib 16 Nivolumab 16 Interleukin-2 14 pembrolizumab 13 Peripheral Blood Stem Cell Transplantation 13 fludarabine phosphate 12 Radiotherapy 12 Interferon-alpha 12 Cyclophosphamide 12 Radiosurgery 11 Filgrastim 11 Blood Specimen Collection 11 Ipilimumab 10 Gemcitabine 10 Axitinib 9 Surveys and Questionnaires 7 Gene Expression Profiling 7 Cryosurgery 7 temsirolimus 6 pazopanib 6 Surgical Procedures, Operative 6 durvalumab 5 cabozantinib 5 atezolizumab 5 Mycophenolic Acid 5 Immunohistochemistry 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Kidney Neoplasms × Hydromorphone × Clear all

NCT05842044 2025-09-05

No-PAIN

University of Miami

Phase 2 Recruiting

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡